SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors aggressively position themselves ahead of the upcoming Phase 2 top-line data readout for ABCL635, a key milestone that the community views as a major clinical validation for the company's AI-driven drug discovery platform. Market participants are intensely debating the stock's potential for a short squeeze and long-term re-rating, fueled by recent institutional accumulation and high-profile pharmaceutical partnerships that have sparked significant speculative volume.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors closely monitor the critical 80th event milestone in the REGAL Phase 3 trial, with mounting speculation regarding institutional accumulation and a potential lucrative buyout. The community remains divided between intense bullish sentiment focused on the stock's role as a groundbreaking oncology platform and bearish concerns over trial timelines and clinical execution.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is trending as investors weigh the company's decision to slow development on its Reko Diq project in Pakistan due to regional security risks, sparking debate over capital expenditure and long-term project viability. The community is actively discussing the stock's valuation and strategic outlook as they balance potential for future production against ongoing geopolitical headwinds.

Themes ETF Trust - Leverage Shares 2X Long SPCX Daily ETF

Leverage Shares 2x Long SPCX Daily ETF

SPCH is experiencing intense trading activity as retail investors utilize the 2x leveraged ETF to capitalize on the high volatility surrounding SpaceX's stock movements. Community discussion is heavily focused on timing entry and exit points amid speculative price swings, with many traders debating the risks of holding leveraged assets versus using them for short-term momentum scalps.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing heightened investor interest and increased volume as the community monitors its performance ahead of an earnings report that analysts expect to be a major catalyst. Market participants are actively debating the potential for a breakout, driven by the company's backlog expansion and competitive positioning in the space launch sector, even as some traders remain cautious regarding volatility surrounding broader sector trends.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is currently trending as investors debate the impact of broader space-sector volatility following recent IPO activity and recurring institutional interest from major tech firms. While some community members express frustration over recent price corrections and equity offerings, others remain focused on the company's long-term geospatial data backlog and its integration into evolving AI and defense infrastructure.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is currently experiencing heightened volatility and intense community scrutiny as investors react to a new patent infringement lawsuit while monitoring technical key levels and upcoming earnings. The community remains polarized, balancing high-conviction excitement over the company's role in AI data center power infrastructure against significant skepticism regarding its ongoing legal challenges and the need for tangible contract announcements.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is trending as a pivotal player in AI infrastructure, driven by intense demand for optical networking components and laser technology as hyperscalers scale compute clusters. The community is actively discussing the stock's role in addressing the physical bottlenecks of data transmission, buoyed by significant strategic investments and a record-breaking backlog that extends through 2028.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is trending as investors monitor supply chain shifts, including potential U.S. restrictions on Chinese optical components, while preparing for critical earnings catalysts that highlight the company's role as a bottleneck in the booming AI infrastructure buildout. The community is actively debating the durability of the AI optics trade, balancing concerns over valuation pullbacks with strong institutional confidence in the sector's long-term capacity requirements.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing heightened retail debate as investors weigh the long-term potential of the company's strategic shift and eBay investment against persistent dilution concerns. Sentiment remains deeply polarized, with the community actively tracking institutional accumulation, short interest levels, and potential catalysts tied to ongoing corporate negotiations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This new GLP-1 play is on a tear. UBS sees nearly a 50% gain from here

MBX Biosciences has rallied more than 230% over the past year, but there's room for still more upside from current levels, according to UBS...

MBX Biosciences (NASDAQ:MBX) Trading Down 6.3%  - Should You Sell?

MBX Biosciences (NASDAQ:MBX) Trading Down 6.3% - Time to Sell...

MBX Biosciences, Inc. (NASDAQ:MBX) Given Consensus Rating of "Moderate Buy" by Analysts

MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) has received an average recommendation of "Moderate Buy" from the twelve brokerages that are presently covering the stock, MarketBeat Ratings...

MBX Biosciences, Inc. (NASDAQ:MBX) Short Interest Up 20.4% in March

MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling...

MBX Biosciences (NASDAQ:MBX) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered MBX Biosciences from a "hold" rating to a "sell" rating in a research report on Saturday...

MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading Volume - What's Next?

MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading Volume - Time to Buy...

Lifesci Capital Weighs in on MBX Biosciences Q1 Earnings

MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) - Analysts at Lifesci Capital issued their Q1 2026 earnings estimates for MBX Biosciences in a report released on Tuesday, March 31st. Lifesci Capital analyst P. Dolezal anticipates that the company will post earnings of ($0.66) per share for the quar...

MBX Biosciences (NASDAQ:MBX) Upgraded at Lifesci Capital

Lifesci Capital raised MBX Biosciences to a "strong-buy" rating in a report on Tuesday...

MBX Biosciences (NASDAQ:MBX) Shares Up 8.5% - What's Next?

MBX Biosciences (NASDAQ:MBX) Stock Price Up 8.5% - What's Next...

MBX Biosciences, Inc. (NASDAQ:MBX) Sees Large Increase in Short Interest

MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling 2,983,725 shares, a growth of 24.6% from the February 26th total of 2,395,339 shares. Based on an average...

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.

MBX Biosciences Inc.

MBX Stock Soars Pre-Market After Investigational Hypoparathyroidism Drug Yields Positive Results In Study

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

MBXMBX Biosciences Inc.

Fundamentals

Connect Stocktwits to ChatGPT

Latest MBX News